Ukrainian Business Saved in Great Britain: What Happens to the Claire's Network.

CLAIRE's Agreement

According to The Sun: The retail company CLAIRE's has signed an agreement with investment firm Modella Capital for the sale of 156 of its stores in Great Britain and Ireland. This occurred just weeks after entering administration.

This step opens up prospects for the accessories brand but raises questions about 145 other stores and 1,000 employees.

The administrators from Interpath confirmed the agreement under which about 1,000 employees will transfer to Modella.

This agreement will secure the majority of Claire's operations in Great Britain and support its presence in urban centers.

Interpath also noted that other stores will remain open 'for as long as possible' while various options are explored.

“Following the agreement between Modella Capital and Ames Watson in the USA, we are pleased to confirm the sale of most of Claire's stores and assets in Great Britain,” said Interpath CEO Natasha Harbinson.

The company appointed administrators for its business in Great Britain and Ireland after filing for bankruptcy in the USA.

Modella has become a key player in British retail after previously acquiring the news agency network WH Smith and taking control of the arts and crafts retailer Hobbycraft.

The WH Smith network, which does not include stores in travel locations, is currently being rebranded to TG Jones.

EXPANSION OF POST SERVICE

The post offices have planned to expand their service offerings, including accepting prescriptions, digital identities, and consulting for small businesses.

The company has introduced a range of measures to boost profitability and has called on the government to protect its network of 11,500 branches and consider tax relief for businesses in difficult situations.

“The postal service has been an essential part of daily life for Britons for almost 400 years. But like any modern retailer, we must evolve to meet consumer demands,” said CEO Neil Brocklehurst.

ASTRAZENECA PLANS

Pharmaceutical giant AstraZeneca announced that it plans to directly list its shares on the New York Stock Exchange.

This IPO, which will begin in February, will replace trading through American Depositary Receipts.

The aim is to attract a broader spectrum of global investors, although this will not affect the company's headquarters in Cambridge or the primary listing in London.

The planned changes will be put to a vote at the annual meeting in November.

RESIGNATION OF GSK CEO

Lady Emma Walmsley steps down after eight years as CEO of GSK.

She became the first woman to run a major pharmaceutical company in 2017.

The head of the commercial department, Luke Mills, will assume all powers early next year.

Lady Emma commented that she looks forward to “seeing GSK's successes in the future while preparing for her own new adventures.”

These events signify important changes in the British business environment, particularly in retail and the pharmaceutical sector. The agreement with Modella Capital could mark a fresh start for CLAIRE's, while AstraZeneca plans to expand its presence in the American market through a direct IPO. The new offerings from the postal service are expected to significantly improve its financial stability under the current market conditions.